Spots Global Cancer Trial Database for metastases, neoplasm
Every month we try and update this database with for metastases, neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases | NCT02265549 | Metastases, Neo... | 18 Years - | Maastricht Radiation Oncology | ||
| A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium | NCT00035061 | Urologic Neopla... Metastases, Neo... | pemetrexed | 18 Years - | Eli Lilly and Company | |
| Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole | NCT00038038 | Squamous Cell C... Head and Neck N... Metastases, Neo... | 18F-fluoromison... PET scan | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel | NCT00039780 | Breast Neoplasm... Breast Diseases Metastases, Neo... | BNP7787 Placebo | 18 Years - | BioNumerik Pharmaceuticals, Inc. | |
| Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) | NCT00034697 | Metastases, Neo... Carcinoma, Non-... Brain Neoplasms | temozolomide | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer | NCT00040560 | Lung Neoplasms Carcinoma, Non-... Brain Neoplasms Metastases, Neo... | 111In-DAC Diagnostic | 18 Years - | Copharos | |
| Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) | NCT00050336 | Carcinoma, Non-... Metastases, Neo... | Lonafarnib (SAR... | 18 Years - | Merck Sharp & Dohme LLC | |
| A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer | NCT00055471 | Prostatic Neopl... Metastases, Neo... | ZD4054 10 mg ZD4054 15 mg ZD4054 22.5 mg | 18 Years - | AstraZeneca | |
| This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer | NCT00034918 | Breast Neoplasm... Metastases, Neo... | ZD6474 | 18 Years - | Sanofi | |
| Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma | NCT00056173 | Carcinoma, Rena... Metastases, Neo... | GTI-2040 | 18 Years - | Aptose Biosciences Inc. | |
| High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors | NCT00037869 | Neuroendocrine ... Metastases, Neo... | I-131 Metaiodob... | 2 Years - | M.D. Anderson Cancer Center | |
| Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole | NCT00038038 | Squamous Cell C... Head and Neck N... Metastases, Neo... | 18F-fluoromison... PET scan | 18 Years - | M.D. Anderson Cancer Center | |
| Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases | NCT02265549 | Metastases, Neo... | 18 Years - | Maastricht Radiation Oncology | ||
| Surgical Treatment of Pancreatic RCC Metastases | NCT03670992 | Renal Cell Carc... Metastases, Neo... | duodenal-pancre... | - | Azienda Policlinico Umberto I | |
| Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART) | NCT03563326 | Neoplasm, Stoma... Metastases, Neo... Neoplasm Seedin... | CAR-T cells tar... Chemotherapy | 18 Years - 75 Years | West China Hospital | |
| A Study in Patients With Advanced or Metastatic Cancer | NCT01115751 | Metastases, Neo... | LY2780301 | 18 Years - | Eli Lilly and Company | |
| A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors | NCT01115803 | Metastases, Neo... Carcinoma, Non-... Renal Cell Carc... Neuroendocrine ... | LY2584702 Erlotinib Everolimus | 18 Years - | Eli Lilly and Company | |
| Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | NCT00046527 | Breast Neoplasm... Metastases, Neo... | ABI-007 | 16 Years - | Celgene Corporation | |
| Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients | NCT00037609 | Breast Neoplasm... Metastases, Neo... | Capecitabine Exisulind | - | M.D. Anderson Cancer Center | |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | NCT00041808 | Metastases, Neo... Colorectal Neop... Esophageal Neop... Stomach Neoplas... Pancreatic Neop... Breast Neoplasm... Melanoma Sarcoma Gastrointestina... Lung Neoplasms Liver Neoplasms Cholangiocarcin... | MTC-DOX for Inj... Chemotherapy | 18 Years - 80 Years | FeRx | |
| Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma | NCT00044863 | Colorectal Neop... Metastases, Neo... | Erbitux (Cetuxi... | 18 Years - | Eli Lilly and Company | |
| Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | NCT00046527 | Breast Neoplasm... Metastases, Neo... | ABI-007 | 16 Years - | Celgene Corporation | |
| A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | NCT00035035 | Pancreatic Neop... Metastases, Neo... | GEMZAR ALIMTA | 18 Years - | Eli Lilly and Company | |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | NCT00041808 | Metastases, Neo... Colorectal Neop... Esophageal Neop... Stomach Neoplas... Pancreatic Neop... Breast Neoplasm... Melanoma Sarcoma Gastrointestina... Lung Neoplasms Liver Neoplasms Cholangiocarcin... | MTC-DOX for Inj... Chemotherapy | 18 Years - 80 Years | FeRx | |
| Surgical Treatment of Pancreatic RCC Metastases | NCT03670992 | Renal Cell Carc... Metastases, Neo... | duodenal-pancre... | - | Azienda Policlinico Umberto I | |
| Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas | NCT05419518 | Neoplasm Metast... Metastases, Neo... | EXTERNAL BEAM R... | 18 Years - | Rutgers, The State University of New Jersey | |
| Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel | NCT00039780 | Breast Neoplasm... Breast Diseases Metastases, Neo... | BNP7787 Placebo | 18 Years - | BioNumerik Pharmaceuticals, Inc. | |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | NCT00041808 | Metastases, Neo... Colorectal Neop... Esophageal Neop... Stomach Neoplas... Pancreatic Neop... Breast Neoplasm... Melanoma Sarcoma Gastrointestina... Lung Neoplasms Liver Neoplasms Cholangiocarcin... | MTC-DOX for Inj... Chemotherapy | 18 Years - 80 Years | FeRx | |
| Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) | NCT00050336 | Carcinoma, Non-... Metastases, Neo... | Lonafarnib (SAR... | 18 Years - | Merck Sharp & Dohme LLC | |
| Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole | NCT00038038 | Squamous Cell C... Head and Neck N... Metastases, Neo... | 18F-fluoromison... PET scan | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
